Mark G. Lebwohl
Mark G. Lebwohl is an American dermatologist and author who is Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology and the Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai in New York City.Lebwohl's books include the book on dermatologic therapy, ''Treatment of Skin Disease'' (), as well as ''Atlas of the Skin and Systemic Disease'' (). He has authored more than 500 publications, multiple book chapters and has been named as one of New York Magazine’s “Best Doctors” every year since the inception of the annual list. Dr. Brian S. Kim is director of a Center for Neuroinflammation and Sensation named in Mark Lebwohl's honor at Icahn School of Medicine at Mount Sinai. Provided by Wikipedia
Showing 1 - 19 results of 19 for search 'Mark Lebwohl', query time: 0.33s
Refine Results
-
1
-
2
-
3
-
4
Stasis dermatitis: A challenging patient journey by Mark Lebwohl, Robert S. Kirsner, David J. Margolis, Benjamin Barankin, Takashi Hashimoto, Juliana M. Canosa, Amy Cha
Published 2023-12-01
Article -
5
-
6
-
7
-
8
Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry by Bruce Strober, Kristina Callis Duffin, Mark Lebwohl, Adam Sima, Jud Janak, Manish Patel, Huzefa Photowala, Vishvas Garg, Jerry Bagel
Published 2024-12-01
Article -
9
-
10
Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials by Alice B. Gottlieb, Jashin J. Wu, Christopher E. M. Griffiths, Kwaku Marfo, Elisa Muscianisi, Xiangyi Meng, Jennifer Frueh, Mark Lebwohl
Published 2022-04-01
Article -
11
Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials by Saxon D. Smith, Alexandros Stratigos, Matthias Augustin, Jose Manuel Carrascosa, Susanne Grond, Elisabeth Riedl, Wen Xu, Himanshu Patel, Mark Lebwohl
Published 2023-06-01
Article -
12
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3) by Kristian Reich, Craig Leonardi, Mark Lebwohl, Francisco Kerdel, Yukari Okubo, Ricardo Romiti, Orin Goldblum, Ellen B. Dennehy, Lisa Kerr, Howard Sofen
Published 2017-05-01
Article -
13
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel by Joshua Burshtein, Milaan Shah, Danny Zakria, Benjamin Lockshin, Jeff Crowley, Joseph F. Merola, Ken Gordon, Mona Shahriari, Neil J. Korman, Raj Chovatiya, Robert Kalb, Mark Lebwohl
Published 2024-02-01
Article -
14
Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials by Rui Sun, Mercedes Bustamante, Venkatesh Kumar Gurusamy, Mark Lebwohl, Alice B. Gottlieb, Philip J. Mease, Atul Deodhar, Weibin Bao, Meryl Mendelson, Brian Porter, Deepa Chand, Victor Dong
Published 2024-03-01
Article -
15
Biological treatment for psoriasis and the risk of herpes zoster: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) by Guy Shalom, Luigi Naldi, Mark Lebwohl, Arjen Nikkels, Elke M. G. J. de Jong, Steven Fakharzadeh, Kavitha G. Goyal, Bhaskar Srivastava, Wayne Langholff, Claudia Galindo, Arnon D. Cohen
Published 2019-08-01
Article -
16
Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Stu... by Paolo Gisondi, Alice B. Gottlieb, Boni Elewski, Matthias Augustin, Sandy McBride, Tsen-Fang Tsai, Christine de la Loge, Frederik Fierens, José M. López Pinto, Nicola Tilt, Mark Lebwohl
Published 2023-05-01
Article -
17
Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CI... by Paolo Gisondi, Alice B. Gottlieb, Boni Elewski, Matthias Augustin, Sandy McBride, Tsen-Fang Tsai, Christine de la Loge, Frederik Fierens, José M. López Pinto, Nicola Tilt, Mark Lebwohl
Published 2022-12-01
Article -
18
The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and... by Daniel C. Butler, Eric Simpson, Emma Guttman-Yassky, Lawrence F. Eichenfield, Alexandra K. Golant, John Y. M. Koo, April W. Armstrong, Andrew F. Alexis, Peter A. Lio, Justin W. Marson, Mark Lebwohl
Published 2022-05-01
Article -
19
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trial... by Atul Deodhar, Andrew Blauvelt, Mark Lebwohl, Meghan Feely, Andris Kronbergs, Nadezhda Eberhart, Danting Zhu, Elsa Inman, Elsie Grace, Thorsten Holzkaemper, Proton Rahman, Helena Marzo-Ortega, Kim A. Papp, Joseph F. Merola, Alice B. Gottlieb, Sergio Schwartzman
Published 2024-02-01
Article